Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A team of medical research and statistical modelling experts at Oxford University and the Alan Turing Institute have conducted a joint analysis to assess the impact of the NHS COVID-19 contact tracing app.

Phone screen showing the app in use

The research suggests the app stopped between 200,000 and 900,000 infections between 1st October and 31st December 2020, when 1.9 million people were infected with coronavirus in England and Wales.

Christophe Fraser, Professor of Pathogen Dynamics at Oxford University’s Big Data Institute, Nuffield Department of Medicine, explains: 'We used two separate approaches to analyse the impact of the more than 1.5 million notifications sent by the app in 2020, and both showed that between 200,000 and 900,000 infections have been averted. The impact of the app could be increased if more people use it. For each 1% increase in users we estimate the number of cases will drop by between 0.8% and 2.3%.'

The report shows the app was downloaded onto over 21 million phones, out of 33.7 million eligible people with compatible smartphones living in England and Wales. In 2020, the app sent out an average of 4.4 quarantine notifications for each user who shared their positive test result though the app. Most alerts went out in the second half of December when cases were rising rapidly across the UK due to the new B117 variant.

Read the full story on the University of Oxford website.

The story is also featured in the Fraser Group Coronavirus blog.

Similar stories

Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age

A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.

Drug could help diabetic hearts recover after heart attack - Oxford research

Researchers at the University of Oxford have identified a drug that could ultimately help improve heart function in people with diabetes who have heart attacks.

Largest ever global study of tuberculosis identifies genetic causes of drug resistance

Using cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis (TB) drug treatments.

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health (FPH) has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby (Nuffield Department of Medicine) for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.

Researchers set out steps to address mental health effects of the pandemic on young people

Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.